Abstract
Preeclampsia is a life-threatening vascular disorder of pregnancy due to a failing stressed placenta. Millions of women risk death to give birth each year and globally each year, almost 300,000 lose their life in this process and over 500,000 babies die as a consequence of preeclampsia. Despite decades of research, we lack pharmacological agents to treat it. Maternal endothelial oxidative stress is a central phenomenon responsible for the preeclampsia phenotype of high maternal blood pressure and proteinuria. In 1997, it was proposed that preeclampsia arises due to the loss of VEGF activity, possibly due to elevation in anti-angiogenic factor, soluble Flt-1 (sFlt-1). Researchers showed that high sFlt-1 and soluble endoglin (sEng) elicit the severe preeclampsia phenotype in pregnant rodents. We demonstrated that heme oxygenase-1 (HO-1)/carbon monoxide (CO) pathway prevents placental stress and suppresses sFlt-1 and sEng release. Likewise, hydrogen sulphide (H2S)/cystathionine-γ-lyase (Cth) systems limit sFlt-1 and sEng and protect against the preeclampsia phenotype in mice. Importantly, H2S restores placental vasculature, and in doing so improves lagging fetal growth. These molecules act as the inhibitor systems in pregnancy and when they fail, preeclampsia is triggered. In this review, we discuss what are the hypotheses and models for the pathophysiology of preeclampsia on the basis of Bradford Hill causation criteria for disease causation and how further in vivo experimentation is needed to establish ‘proof of principle’. Hypotheses that fail to meet the Bradford Hill causation criteria include abnormal spiral artery remodelling and inflammation and should be considered associated or consequential to the disorder. In contrast, the protection against cellular stress hypothesis that states that the protective pathways mitigate cellular stress by limiting elevation of anti-angiogenic factors or oxidative stress and the subsequent clinical signs of preeclampsia appear to fulfil most of Bradford Hill causation criteria. Identifying the candidates on the roadmap to this pathway is essential in developing diagnostics and therapeutics to target the pathogenesis of preeclampsia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acevedo CH, Ahmed A (1998) Hemeoxygenase-1 inhibits human myometrial contractility via carbon monoxide and is upregulated by progesterone during pregnancy. J Clin Invest 101(5):949–955
Ahmad S, Ahmed A (2001) Regulation of soluble VEGFR-1 by VEGF and oxygen and its elevation in pre-eclampsia and fetal growth restriction. Placenta 22(8–9):A.7
Ahmad S, Ahmed A (2004) Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 95(9):884–891
Ahmad S, Hewett PW, Wang P, Al-Ani B, Cudmore M, Fujisawa T et al (2006) Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis. Circ Res 99(7):715–722
Ahmad S, Hewett PW, Al-Ani B, Sissaoui S, Fujisawa T, Cudmore MJ et al (2011) Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis. Vasc Cell 3(1):15
Ahmed A (1997) Heparin-binding angiogenic growth factors in pregnancy. Trophoblast Res 10:215–258
Ahmed A, Ramma W (2015) Unravelling the theories of pre-eclampsia: are the protective pathways the new paradigm? Br J Pharmacol 172(6):1574–1586
Ahmed A, Rahman M, Zhang X, Acevedo CH, Nijjar S, Rushton I et al (2000) Induction of placental heme oxygenase-1 is protective against TNFalpha- induced cytotoxicity and promotes vessel relaxation. Mol Med 6(5):391–409
Al-Ani B, Hewett PW, Cudmore MJ, Fujisawa T, Saifeddine M, Williams H et al (2010) Activation of proteinase-activated receptor 2 stimulates soluble vascular endothelial growth factor receptor 1 release via epidermal growth factor receptor transactivation in endothelial cells. Hypertension 55(3):689–697
Alpoim PN, Godoi LC, Pinheiro Mde B, Freitas LG, Carvalho M, Dusse LM (2016) The unexpected beneficial role of smoking in preeclampsia. Clin Chim Acta 459:105–108
Arulkumaran N, Lightstone L (2013) Severe pre-eclampsia and hypertensive crises. Best Pract Res Clin Obstet Gynaecol 27(6):877–884
Bachmayer N, Rafik Hamad R, Liszka L, Bremme K, Sverremark-Ekstrom E (2006) Aberrant uterine natural killer (NK)-cell expression and altered placental and serum levels of the NK-cell promoting cytokine interleukin-12 in pre-eclampsia. Am J Reprod Immunol 56(5–6):292–301
Bainbridge SA, Farley AE, McLaughlin BE, Graham CH, Marks GS, Nakatsu K et al (2002) Carbon monoxide decreases perfusion pressure in isolated human placenta. Placenta 23(8–9):563–569
Bartsch E, Medcalf KE, Park AL, Ray JG (2016) High risk of pre-eclampsia identification G. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ 353:i1753
Baum M, Schiff E, Kreiser D, Dennery PA, Stevenson DK, Rosenthal T et al (2000) End-tidal carbon monoxide measurements in women with pregnancy-induced hypertension and preeclampsia. Am J Obstet Gynecol 183(4):900–903
Bell MJ (2010) A historical overview of preeclampsia-eclampsia. J Obstet Gynecol Neonatal Nurs 39(5):510–518
Bendall JK, Alp NJ, Warrick N, Cai S, Adlam D, Rockett K et al (2005) Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression. Circ Res 97(9):864–871
Bergmann A, Ahmad S, Cudmore M, Gruber AD, Wittschen P, Lindenmaier W et al (2010) Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model. J Cell Mol Med 14(6B):1857–1867
Blackstone E, Roth MB (2007) Suspended animation-like state protects mice from lethal hypoxia. Shock 27(4):370–372
Brosens JJ, Pijnenborg R, Brosens IA (2002) The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol 187(5):1416–1423
Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM (2001) The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20(1):IX–XIV
Burke SD, Karumanchi SA (2013) Spiral artery remodeling in preeclampsia revisited. Hypertension 62(6):1013–1014
Burke SD, Barrette VF, Bianco J, Thorne JG, Yamada AT, Pang SC et al (2010) Spiral arterial remodeling is not essential for normal blood pressure regulation in pregnant mice. Hypertension 55(3):729–737
Burton GJ, Woods AW, Jauniaux E, Kingdom JC (2009) Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 30(6):473–482
Bussolati B, Dunk C, Grohman M, Kontos CD, Mason J, Ahmed A (2001) Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol 159(3):993–1008
Caniggia I, Lye SJ, Cross JC (1997) Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology 138(9):3976–3986
Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M et al (2000) Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest 105(5):577–587
Carter AM, Enders AC, Pijnenborg R (2015) The role of invasive trophoblast in implantation and placentation of primates. Philos Trans R Soc Lond B Biol Sci 370(1663):20140070
Carty DM, Anderson LA, Freeman DJ, Welsh PI, Brennand JE, Dominiczak AF et al (2012) Early pregnancy soluble E-selectin concentrations and risk of preeclampsia. J Hypertens 30(5):954–959
Chappell LC, Duckworth S, Seed PT, Griffin M, Myers J, Mackillop L et al (2013) Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation 128(19):2121–2131
Chen J, Kuhlencordt P, Urano F, Ichinose H, Astern J, Huang PL (2003) Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice. Arterioscler Thromb Vasc Biol 23(1):97–103
Cheng SB, Sharma S (2016) Preeclampsia and health risks later in life: an immunological link. Semin Immunopathol
Cindrova-Davies T, Sanders DA, Burton GJ, Charnock-Jones DS (2011) Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling. Cardiovasc Res 89(3):671–679
Cindrova-Davies T, Herrera EA, Niu Y, Kingdom J, Giussani DA, Burton GJ (2013) Reduced cystathionine gamma-lyase and increased microRNA-21 expression are associated with increased vascular resistance in growth-restricted pregnancies: hydrogen sulfide as a placental vasodilator. Am J Pathol
Cross SN, Ratner E, Rutherford TJ, Schwartz PE, Norwitz ER (2012) Bevacizumab-mediated interference with VEGF signaling is sufficient to induce a preeclampsia-like syndrome in nonpregnant women. Rev Obstet Gynecol 5(1):2–8
Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K et al (2007) Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 115(13):1789–1797
Cudmore MJ, Ahmad S, Sissaoui S, Ramma W, Ma B, Fujisawa T et al (2011) Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1. Eur Heart J
D’Uscio LV, Baker TA, Mantilla CB, Smith L, Weiler D, Sieck GC et al (2001) Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21(6):1017–1022
Dai Y, Diao Z, Sun H, Li R, Qiu Z, Hu Y (2011) MicroRNA-155 is involved in the remodelling of human-trophoblast-derived HTR-8/SVneo cells induced by lipopolysaccharides. Hum Reprod 26(7):1882–1891
Dai B, Liu T, Zhang B, Zhang X, Wang Z (2013) The polymorphism for endothelial nitric oxide synthase gene, the level of nitric oxide and the risk for pre-eclampsia: a meta-analysis. Gene 519(1):187–193
Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, Kolarz B, Rolinski J, Leszczynska-Gorzelak B et al (2012) The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol 93(2):75–81
Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T (2002) Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. Bjog 109(7):759–764
Dulak J, Deshane J, Jozkowicz A, Agarwal A (2008) Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 117(2):231–241
Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L et al (2007) Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A 104(39):15560–15565
Farina A, Sekizawa A, De Sanctis P, Purwosunu Y, Okai T, Cha DH et al (2008) Gene expression in chorionic villous samples at 11 weeks’ gestation from women destined to develop preeclampsia. Prenat Diagn 28(10):956–961
Farzadnia M, Ayatollahi H, Hasan-Zade M, Rahimi HR (2013) A comparative study of serum level of Vascular Cell Adhesion Molecule-1 (sVCAM-1), Intercellular Adhesion Molecule-1(ICAM-1) and high sensitive C–Reactive Protein (hs-CRP) in normal and pre-eclamptic pregnancies. Iran J Basic Med Sci 16(5):689–693
Feinberg RF, Kliman HJ, Cohen AW (1991) Preeclampsia, trisomy 13, and the placental bed. Obstet Gynecol 78(3 Pt 2):505–508
Fu B, Li X, Sun R, Tong X, Ling B, Tian Z et al (2013) Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface. Proc Natl Acad Sci U S A 110(3):E231–E240
Garovic VD, Hayman SR (2007) Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol 3(11):613–622
Genbacev O, Joslin R, Damsky CH, Polliotti BM, Fisher SJ (1996) Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest 97(2):540–550
George EM, Cockrell K, Aranay M, Csongradi E, Stec DE, Granger JP (2011) Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension 57(5):941–948
Gude NM, King RG, Brennecke SP (1990) Role of endothelium-derived nitric oxide in maintenance of low fetal vascular resistance in placenta. Lancet 336(8730):1589–1590
He H, Venema VJ, Gu X, Venema RC, Marrero MB, Caldwell RB (1999) Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem 274(35):25130–25135
Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T (2001) Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104(22):2673–2678
Higashi Y (1995) Intravenous administration of L-arginine inhibits angiotensin- converting enzyme in humans. J Clin Endocrinol Metab 80(7):2198–2202
Hill AB (1965) The environment and disease: association or causation? Proc R Soc Med 58:295–300
Hladunewich M, Karumanchi SA, Lafayette R (2007) Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol 2(3):543–549
Holwerda KM, Bos EM, Rajakumar A, Ris-Stalpers C, van Pampus MG, Timmer A et al (2012) Hydrogen sulfide producing enzymes in pregnancy and preeclampsia. Placenta
Hong F, Li Y, Xu Y (2014) Decreased placental miR-126 expression and vascular endothelial growth factor levels in patients with pre-eclampsia. J Int Med Res 42(6):1243–1251
Huppertz B, Weiss G, Moser G (2014) Trophoblast invasion and oxygenation of the placenta: measurements versus presumptions. J Reprod Immunol 101–102:74–79
Jabecka A, Ast J, Bogdaski P, Drozdowski M, Pawlak-Lemaska K, Cielewicz AR et al (2012) Oral L-arginine supplementation in patients with mild arterial hypertension and its effect on plasma level of asymmetric dimethylarginine, L-citruline, L-arginine and antioxidant status. Eur Rev Med Pharmacol Sci 16(12):1665–1674
Jebbink J, Keijser R, Veenboer G, van der Post J, Ris-Stalpers C, Afink G (2011) Expression of placental FLT1 transcript variants relates to both gestational hypertensive disease and fetal growth. Hypertension 58(1):70–76
Jeong JH, Kim HG, Choi OH (2014) Sildenafil inhibits advanced glycation end products-induced sFlt-1 release through upregulation of heme oxygenase-1. J Menop Med 20(2):57–68
Kaartokallio T, Klemetti MM, Timonen A, Uotila J, Heinonen S, Kajantie E et al (2014) Microsatellite polymorphism in the heme oxygenase-1 promoter is associated with nonsevere and late-onset preeclampsia. Hypertension 64(1):172–177
Kang JH, Farina A, Park JH, Kim SH, Kim JY, Rizzo N et al (2008) Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity. Prenat Diagn 28(8):704–709
Khong TY, De Wolf F, Robertson WB, Brosens I (1986) Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 93(10):1049–1059
Kondo K, Bhushan S, King AL, Prabhu SD, Hamid T, Koenig S et al (2013) H(2)S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase. Circulation 127(10):1116–1127
Kronborg CS, Gjedsted J, Vittinghus E, Hansen TK, Allen J, Knudsen UB (2011) Longitudinal measurement of cytokines in pre-eclamptic and normotensive pregnancies. Acta Obstet Gynecol Scand 90(7):791–796
Kukor Z, Valent S, Toth M (2000) Regulation of nitric oxide synthase activity by tetrahydrobiopterin in human placentae from normal and pre-eclamptic pregnancies. Placenta 21(8):763–772
Kumasawa K, Ikawa M, Kidoya H, Hasuwa H, Saito-Fujita T, Morioka Y et al (2011) Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc Natl Acad Sci U S A 108(4):1451–1455
Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T (2002) Identification of tissue-specific microRNAs from mouse. Curr Biol 12(9):735–739
Learmont JG, Poston L (1996) Nitric oxide is involved in flow-induced dilation of isolated human small fetoplacental arteries. Am J Obstet Gynecol 174(2):583–588
Leffler CW, Parfenova H, Jaggar JH, Wang R (2006) Carbon monoxide and hydrogen sulfide: gaseous messengers in cerebrovascular circulation. J Appl Physiol (1985) 100(3):1065–1076
Leno-Duran E, Hatta K, Bianco J, Yamada AT, Ruiz-Ruiz C, Olivares EG et al (2010) Fetal-placental hypoxia does not result from failure of spiral arterial modification in mice. Placenta 31(8):731–737
Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF et al (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350(7):672–683
Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP et al (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355(10):992–1005
Li F, Hagaman JR, Kim HS, Maeda N, Jennette JC, Faber JE et al (2012) eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype. J Am Soc Nephrol 23(4):652–660
Li X, Li C, Dong X, Gou W (2014) MicroRNA-155 inhibits migration of trophoblast cells and contributes to the pathogenesis of severe preeclampsia by regulating endothelial nitric oxide synthase. Mol Med Rep 10(1):550–554
Linzke N, Schumacher A, Woidacki K, Croy BA, Zenclussen AC (2014) Carbon monoxide promotes proliferation of uterine natural killer cells and remodeling of spiral arteries in pregnant hypertensive heme oxygenase-1 mutant mice. Hypertension 63(3):580–588
Liu X, Pan L, Zhuo Y, Gong Q, Rose P, Zhu Y (2010) Hypoxia-inducible factor-1alpha is involved in the pro-angiogenic effect of hydrogen sulfide under hypoxic stress. Biol Pharm Bull 33(9):1550–1554
Llurba E, Gratacos E, Martin-Gallan P, Cabero L, Dominguez C (2004) A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radic Biol Med 37(4):557–570
Lowe DT (2000) Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide 4(4):441–458
Lowe SA, Brown MA, Dekker GA, Gatt S, McLintock CK, McMahon LP et al (2009) Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol 49(3):242–246
Lyall F, Barber A, Myatt L, Bulmer JN, Robson SC (2000) Hemeoxygenase expression in human placenta and placental bed implies a role in regulation of trophoblast invasion and placental function. FASEB J 14(1):208–219
Lyall F, Robson SC, Bulmer JN (2013) Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome. Hypertension 62(6):1046–1054
Maharaj AS, Walshe TE, Saint-Geniez M, Venkatesha S, Maldonado AE, Himes NC et al (2008) VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma. J Exp Med 205(2):491–501
Maloyan A, Mele J, Muralimanohara B, Myatt L (2012) Measurement of mitochondrial respiration in trophoblast culture. Placenta 33(5):456–458
Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S et al (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111(5):649–658
Maynard S, Epstein FH, Karumanchi SA (2008) Preeclampsia and angiogenic imbalance. Annu Rev Med 59:61–78
McCarthy FP, Drewlo S, Kingdom J, Johns EJ, Walsh SK, Kenny LC (2011) Peroxisome proliferator-activated receptor-{gamma} as a potential therapeutic target in the treatment of preeclampsia. Hypertension 58(2):280–286
Mitchell BM, Cook LG, Danchuk S, Puschett JB (2007) Uncoupled endothelial nitric oxide synthase and oxidative stress in a rat model of pregnancy-induced hypertension. Am J Hypertens 20(12):1297–1304
Miyagami S, Koide K, Sekizawa A, Ventura W, Yotsumoto J, Oishi S et al (2013) Physiological changes in the pattern of placental gene expression early in the first trimester. Reprod Sci 20(6):710–714
Mouillet JF, Chu T, Sadovsky Y (2011) Expression patterns of placental microRNAs. Birth Defects Res A Clin Mol Teratol 91(8):737–743
Muralimanoharan S, Maloyan A, Mele J, Guo C, Myatt LG, Myatt L (2012) MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta 33(10):816–823
Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL (1997) Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet 349(9061):1285–1288
Muttukrishna S, North RA, Morris J, Schellenberg JC, Taylor RS, Asselin J et al (2000) Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod 15(7):1640–1645
Myatt L, Webster RP (2009) Vascular biology of preeclampsia. J Thromb Haemost 7(3):375–384
Myatt L, Brewer A, Brockman DE (1991) The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 164(2):687–692
Myatt L, Rosenfield RB, Eis AL, Brockman DE, Greer I, Lyall F (1996) Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension 28(3):488–493
Nagamatsu T, Fujii T, Kusumi M, Li Z, Yamashita T, Osuga Y et al (2004) Cytotrophoblasts up-regulate soluble Fms-like tyrosine kinase-1 (sFlt-1) expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology
Nayeri UA, Buhimschi IA, Laky CA, Cross SN, Duzyj CM, Ramma W et al (2014) Antenatal corticosteroids impact the inflammatory rather than the antiangiogenic profile of women with preeclampsia. Hypertension
Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O (2005) Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 25(3):221–226
Onda K, Tong S, Nakahara A, Kondo M, Monchusho H, Hirano T et al (2015) Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia. Hypertension 65(4):855–862
Ozler A, Turgut A, Sak ME, Evsen MS, Soydinc HE, Evliyaoglu O et al (2012) Serum levels of neopterin, tumor necrosis factor-alpha and Interleukin-6 in preeclampsia: relationship with disease severity. Eur Rev Med Pharmacol Sci 16(12):1707–1712
Palmer KR, Tong S, Tuohey L, Cannon P, Ye L, Hannan NJ et al (2016) Jumonji domain containing protein 6 is decreased in human preeclamptic placentas and regulates sFLT-1 splice variant production. Biol Reprod 94(3):59
Papapetropoulos A, Pyriochou A, Altaany Z, Yang G, Marazioti A, Zhou Z et al (2009) Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci U S A 106(51):21972–21977
Patel P, Vatish M, Heptinstall J, Wang R, Carson RJ (2009) The endogenous production of hydrogen sulphide in intrauterine tissues. Reprod Biol Endocrinol 7:10
Peluffo G, Radi R (2007) Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res 75(2):291–302
Polhemus DJ, Calvert JW, Butler J, Lefer DJ (2014) The cardioprotective actions of hydrogen sulfide in acute myocardial infarction and heart failure. Scientifica (Cairo) 2014:768607
Rajakumar A, Conrad KP (2000a) Expression, ontogeny, and regulation of hypoxia-inducible transcription factors in the human placenta. Biol Reprod 63(2):559–569
Rajakumar A, Conrad KP (2000b) Expression, ontogeny, and regulation of hypoxia-inducible transcription factors in the human placenta. Biol Reprod 63(2):559–569
Rajakumar A, Doty K, Daftary A, Harger G, Conrad KP (2003a) Impaired oxygen-dependent reduction of HIF-1α and -2α proteins in pre-eclamptic placentae. Placenta 24(2–3):199–208
Rajakumar A, Doty K, Daftary A, Harger G, Conrad KP (2003b) Impaired oxygen-dependent reduction of HIF-1alpha and -2alpha proteins in pre-eclamptic placentae. Placenta 24(2–3):199–208
Ramma W, Ahmed A (2011) Is inflammation the cause of pre-eclampsia? Biochem Soc Trans 39(6):1619–1627
Ramma W, Ahmed A (2014) Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia. J Reprod Immunol 101–102:153–160
Ramma W, Buhimschi IA, Zhao G, Dulay AT, Nayeri UA, Buhimschi CS et al (2012) The elevation in circulating anti-angiogenic factors is independent of markers of neutrophil activation in preeclampsia. Angiogenesis
Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308(5728):1592–1594
Redman CW, Sargent IL (2009) Placental stress and pre-eclampsia: a revised view. Placenta 30(Suppl A):S38–S42
Rizos D, Eleftheriades M, Batakis E, Rizou M, Haliassos A, Hassiakos D et al (2012) Levels of asymmetric dimethylarginine throughout normal pregnancy and in pregnancies complicated with preeclampsia or had a small for gestational age baby. J Mater Fetal Neonatal Med 25(8):1311–1315
Roberts JM, Hubel CA (2009) The two stage model of preeclampsia: variations on the theme. Placenta 30(Suppl A):S32–S37
Robson A, Harris LK, Innes BA, Lash GE, Aljunaidy MM, Aplin JD et al (2012) Uterine natural killer cells initiate spiral artery remodeling in human pregnancy. FASEB J 26(12):4876–4885
Salles AM, Galvao TF, Silva MT, Motta LC, Pereira MG (2012) Antioxidants for preventing preeclampsia: a systematic review. ScientificWorldJournal 2012:243476
Sanchez-Aranguren LC, Prada CE, Riano-Medina CE, Lopez M (2014) Endothelial dysfunction and preeclampsia: role of oxidative stress. Front Physiol 5:372
Sankaralingam S, Arenas IA, Lalu MM, Davidge ST (2006) Preeclampsia: current understanding of the molecular basis of vascular dysfunction. Expert Rev Mol Med 8(3):1–20
Sankaralingam S, Xu H, Davidge ST (2010) Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia. Cardiovasc Res 85(1):194–203
Saxena AR, Karumanchi SA, Brown NJ, Royle CM, McElrath TF, Seely EW (2010) Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy. Hypertension 55(5):1239–1245
Schulman SP, Becker LC, Kass DA, Champion HC, Terrin ML, Forman S et al (2006) L-arginine therapy in acute myocardial infarction: the Vascular Interaction with Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA 295(1):58–64
Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–848
Sikorski EM, Hock T, Hill-Kapturczak N, Agarwal A (2004) The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury. Am J Physiol Renal Physiol 286(3):F425–F441
Smith GC, Pell JP, Walsh D (2001) Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 357(9273):2002–2006
Staff AC, Berge L, Haugen G, Lorentzen B, Mikkelsen B, Henriksen T (2004) Dietary supplementation with L-arginine or placebo in women with pre-eclampsia. Acta Obstet Gynecol Scand 83(1):103–107
Stallmach T, Hebisch G, Orban P, Lu X (1999) Aberrant positioning of trophoblast and lymphocytes in the feto-maternal interface with pre-eclampsia. Virchows Arch 434(3):207–211
Szalai G, Xu Y, Romero R, Chaiworapongsa T, Xu Z, Chiang PJ et al (2014) In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy. PLoS One 9(11):e110867
Tao BB, Liu SY, Zhang CC, Fu W, Cai WJ, Wang Y et al (2013) VEGFR2 functions as an H2S-targeting receptor protein kinase with its novel Cys1045-Cys1024 disulfide bond serving as a specific molecular switch for hydrogen sulfide actions in vascular endothelial cells. Antioxid Redox Signal 19(5):448–464
Tenhunen R, Marver HS, Schmid R (1969) Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem 244(23):6388–6394
Thadhani R, Kisner T, Hagmann H, Bossung V, Noack S, Schaarschmidt W et al (2011) Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 124(8):940–950
Thadhani R, Hagmann H, Schaarschmidt W, Roth B, Cingoez T, Karumanchi SA et al (2016) Removal of soluble fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia. J Am Soc Nephrol 27(3):903–913
Thomas CP, Andrews JI, Raikwar NS, Kelley EA, Herse F, Dechend R et al (2009) A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia. J Clin Endocrinol Metab 94(7):2524–2530
Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, Bianchi DW, Burton GJ (2006) Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol 169(2):400–404
Tong S, Kaitu’u-Lino TJ, Onda K, Beard S, Hastie R, Binder NK et al (2015) Heme oxygenase-1 is not decreased in preeclamptic placenta and does not negatively regulate placental soluble fms-like tyrosine kinase-1 or soluble endoglin secretion. Hypertension 66(5):1073–1081
Vadillo-Ortega F, Perichart-Perera O, Espino S, Avila-Vergara MA, Ibarra I, Ahued R et al (2011) Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ 342:d2901
Valbuena-Diez AC, Blanco FJ, Oujo B, Langa C, Gonzalez-Nunez M, Llano E et al (2012) Oxysterol-induced soluble endoglin release and its involvement in hypertension. Circulation 126(22):2612–2624
Veerbeek JH, Brouwers L, Koster MP, Koenen SV, van Vliet EO, Nikkels PG et al (2016) Spiral artery remodeling and maternal cardiovascular risk: the spiral artery remodeling (SPAR) study. J Hypertens 34(8):1570–1577
Venditti CC, Casselman R, Young I, Karumanchi SA, Smith GN (2014) Carbon monoxide prevents hypertension and proteinuria in an adenovirus sFlt-1 preeclampsia-like mouse model. PLoS One 9(9):e106502
Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM et al (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12(6):642–649
Walshe TE, Dole VS, Maharaj AS, Patten IS, Wagner DD, D’Amore PA (2009) Inhibition of VEGF or TGF-{beta} signaling activates endothelium and increases leukocyte rolling. Arterioscler Thromb Vasc Biol 29(8):1185–1192
Wang K, Ahmad S, Cai M, Rennie J, Fujisawa T, Crispi F et al (2013) Dysregulation of hydrogen sulfide producing enzyme cystathionine gamma-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. Circulation 127(25):2514–2522
Wang R, Szabo C, Ichinose F, Ahmed A, Whiteman M, Papapetropoulos A (2015) The role of H2S bioavailability in endothelial dysfunction. Trends Pharmacol Sci 36(9):568–578
Williams PJ, Bulmer JN, Searle RF, Innes BA, Robson SC (2009) Altered decidual leucocyte populations in the placental bed in pre-eclampsia and foetal growth restriction: a comparison with late normal pregnancy. Reproduction 138(1):177–184
Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL (1996) Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A 93(13):6770–6774
Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T et al (1999) Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103(1):129–135
Yan H, Du J, Tang C (2004) The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 313(1):22–27
Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL (2006) Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 20(12):2118–2120
Zenclussen ML, Linzke N, Schumacher A, Fest S, Meyer N, Casalis PA et al (2014) Heme oxygenase-1 is critically involved in placentation, spiral artery remodeling, and blood pressure regulation during murine pregnancy. Front Pharmacol 5:291
Zhang Y, Diao Z, Su L, Sun H, Li R, Cui H et al (2010) MicroRNA-155 contributes to preeclampsia by down-regulating CYR61. Am J Obstet Gynecol 202(5):466 e1–7
Zhao W, Zhang J, Lu Y, Wang R (2001) The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. Embo J 20(21):6008–6016
Zhao H, Wong RJ, Doyle TC, Nayak N, Vreman HJ, Contag CH et al (2008) Regulation of maternal and fetal hemodynamics by heme oxygenase in mice. Biol Reprod 78(4):744–751
Zhao H, Wong RJ, Kalish FS, Nayak NR, Stevenson DK (2009) Effect of heme oxygenase-1 deficiency on placental development. Placenta 30(10):861–868
Zhou Y, Damsky CH, Fisher SJ (1997) Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 99(9):2152–2164
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing AG
About this chapter
Cite this chapter
Ahmed, A., Rezai, H., Broadway-Stringer, S. (2016). Evidence-Based Revised View of the Pathophysiology of Preeclampsia. In: Islam, M.S. (eds) Hypertension: from basic research to clinical practice. Advances in Experimental Medicine and Biology(), vol 956. Springer, Cham. https://doi.org/10.1007/5584_2016_168
Download citation
DOI: https://doi.org/10.1007/5584_2016_168
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-44250-1
Online ISBN: 978-3-319-44251-8
eBook Packages: MedicineMedicine (R0)